Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Apr 3;82(9):1600–1604. doi: 10.1054/bjoc.1999.1182

Tubal ligation and risk of breast cancer

L A Brinton 1, M D Gammon 3, R J Coates 4, R N Hoover 2
PMCID: PMC2363387  PMID: 10789731

Abstract

Although it has been demonstrated in previous studies that tubal ligation can have widespread effects on ovarian function, including a decrease in the risk of subsequent ovarian cancer, few studies have evaluated effects on breast cancer risk. In a population-based case–control study of breast cancer among women 20–54 years of age conducted in three geographic areas, previous tubal ligations were reported by 25.3% of the 2173 cases and 25.8% of the 1990 controls. Initially it appeared that tubal ligations might impart a slight reduction in risk, particularly among women undergoing the procedure at young ages (< 25 years). However, women were more likely to have had the procedure if they were black, less educated, young when they bore their first child, or multiparous. After accounting for these factors, tubal ligations were unrelated to breast cancer risk (relative risk (RR) = 1.09, 95% confidence interval (CI) 0.9–1.3), with no variation in risk by age at, interval since, or calendar year of the procedure. The relationship of tubal ligations to risk did not vary according to the presence of a number of other risk factors, including menopausal status or screening history. Furthermore, effects of tubal ligation were similar for all stages at breast cancer diagnosis. Further studies would be worthwhile given the biologic plausibility of an association. However, future investigations should include information on type of procedure performed (since this may relate to biologic effects) as well as other breast cancer risk factors. © 2000 Cancer Research Campaign

Keywords: breast cancer, tubal ligation, epidemiology

Full Text

The Full Text of this article is available as a PDF (71.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brinton L. A., Daling J. R., Liff J. M., Schoenberg J. B., Malone K. E., Stanford J. L., Coates R. J., Gammon M. D., Hanson L., Hoover R. N. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst. 1995 Jun 7;87(11):827–835. doi: 10.1093/jnci/87.11.827. [DOI] [PubMed] [Google Scholar]
  2. Castellsague X., Thompson W. D., Dubrow R. Tubal sterilization and the risk of endometrial cancer. Int J Cancer. 1996 Mar 1;65(5):607–612. doi: 10.1002/(SICI)1097-0215(19960301)65:5<607::AID-IJC9>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  3. Cattanach J. F., Milne B. J. Post-tubal sterilization problems correlated with ovarian steroidogenesis. Contraception. 1988 Nov;38(5):541–550. doi: 10.1016/0010-7824(88)90157-6. [DOI] [PubMed] [Google Scholar]
  4. DeStefano F., Perlman J. A., Peterson H. B., Diamond E. L. Long-term risk of menstrual disturbances after tubal sterilization. Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 1):835–841. doi: 10.1016/s0002-9378(85)80073-9. [DOI] [PubMed] [Google Scholar]
  5. Donnez J., Wauters M., Thomas K. Luteal function after tubal sterilization. Obstet Gynecol. 1981 Jan;57(1):65–68. [PubMed] [Google Scholar]
  6. Green A., Purdie D., Bain C., Siskind V., Russell P., Quinn M., Ward B. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer. 1997 Jun 11;71(6):948–951. doi: 10.1002/(sici)1097-0215(19970611)71:6<948::aid-ijc6>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  7. Green A., Purdie D., Green L., Dick M. L., Bain C., Siskind V. Validity of self-reported hysterectomy and tubal sterilisation. The Survey of Women's Health Study Group. Aust N Z J Public Health. 1997 Jun;21(3):337–340. doi: 10.1111/j.1467-842x.1997.tb01710.x. [DOI] [PubMed] [Google Scholar]
  8. Hakverdi A. U., Taner C. E., Erden A. C., Satici O. Changes in ovarian function after tubal sterilization. Adv Contracept. 1994 Mar;10(1):51–56. doi: 10.1007/BF01986530. [DOI] [PubMed] [Google Scholar]
  9. Hankinson S. E., Hunter D. J., Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Hennekens C. H., Speizer F. E. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA. 1993 Dec 15;270(23):2813–2818. [PubMed] [Google Scholar]
  10. Helm G., Sjöberg N. O. Progesterone levels before and after laparoscopic tubal sterilization using endotherm coagulation. Acta Obstet Gynecol Scand. 1983;62(1):63–66. doi: 10.3109/00016348309155761. [DOI] [PubMed] [Google Scholar]
  11. Irwin K. L., Lee N. C., Peterson H. B., Rubin G. L., Wingo P. A., Mandel M. G. Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol. 1988 Jun;127(6):1192–1201. doi: 10.1093/oxfordjournals.aje.a114912. [DOI] [PubMed] [Google Scholar]
  12. Kreiger N., Sloan M., Cotterchio M., Kirsh V. The risk of breast cancer following reproductive surgery. Eur J Cancer. 1999 Jan;35(1):97–101. doi: 10.1016/s0959-8049(98)00343-8. [DOI] [PubMed] [Google Scholar]
  13. Kreiger N., Sloan M., Cotterchio M., Parsons P. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol. 1997 Aug;26(4):710–715. doi: 10.1093/ije/26.4.710. [DOI] [PubMed] [Google Scholar]
  14. La Vecchia C. Reproductive surgery, menopause and breast cancer risk. Eur J Cancer. 1999 Jan;35(1):12–13. doi: 10.1016/s0959-8049(98)00351-7. [DOI] [PubMed] [Google Scholar]
  15. Miracle-McMahill H. L., Calle E. E., Kosinski A. S., Rodriguez C., Wingo P. A., Thun M. J., Heath C. W., Jr Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol. 1997 Feb 15;145(4):349–357. doi: 10.1093/oxfordjournals.aje.a009112. [DOI] [PubMed] [Google Scholar]
  16. Neil J. R., Hammond G. T., Noble A. D., Rushton L., Letchworth A. T. Late complications of sterilisation by laparoscopy and tubal ligation. A controlled study. Lancet. 1975 Oct 11;2(7937):699–700. doi: 10.1016/s0140-6736(75)90789-8. [DOI] [PubMed] [Google Scholar]
  17. Rosenblatt K. A., Thomas D. B. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):933–935. [PubMed] [Google Scholar]
  18. Swanson C. A., Coates R. J., Malone K. E., Gammon M. D., Schoenberg J. B., Brogan D. J., McAdams M., Potischman N., Hoover R. N., Brinton L. A. Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology. 1997 May;8(3):231–237. doi: 10.1097/00001648-199705000-00001. [DOI] [PubMed] [Google Scholar]
  19. Swanson C. A., Coates R. J., Schoenberg J. B., Malone K. E., Gammon M. D., Stanford J. L., Shorr I. J., Potischman N. A., Brinton L. A. Body size and breast cancer risk among women under age 45 years. Am J Epidemiol. 1996 Apr 1;143(7):698–706. doi: 10.1093/oxfordjournals.aje.a008803. [DOI] [PubMed] [Google Scholar]
  20. Sørensen T., Ladehoff P. Sene komplikationer efter sterilisation af kvinder. Ugeskr Laeger. 1979 Apr 9;141(15):998–999. [PubMed] [Google Scholar]
  21. Thompson W. D. Statistical analysis of case-control studies. Epidemiol Rev. 1994;16(1):33–50. doi: 10.1093/oxfordjournals.epirev.a036143. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES